AKUMS
Akums Drugs and PharmaceuticalHealthcare
LTP
804.85
CHG · %
-8.65 (-1.06%)
VOL · TODAY
57.47K
PREV CLOSE
813.5
Today's range802.45 · 825.65
804.85
52-week range409.3 · 838.8
804.85
Loading candles…
Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and operates as a pharmaceutical contract development and manufacturing organization (CDMO). The company provides a range of pharmaceutical products and services including formulation development, bio-equivalence studies, manufacturing, and regulatory compliance. Serving both the Indian market and over 70 other countries, Akums is active in the pharmaceutical industry and is recognized as a dominant player within the Indian pharmaceutical CDMO sector. It caters to major domestic and international pharmaceutical companies. The company does not have any publicly noted subsidiaries, founders, or listings on stock exchanges.
AKUMS is not part of any active scan today.
This page is a live market overview for Akums Drugs and Pharmaceutical (AKUMS) on the BSE. As a listed security, Akums Drugs and Pharmaceutical is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AKUMS before placing trades on tick2trade.
As of the latest feed, AKUMS last traded at ₹804.85 on BSE, down ₹8.65 (1.06%) from the previous close of ₹813.5. Today's session range is ₹802.45 – ₹825.65, against a 52-week band of ₹409.3 – ₹838.8. Traded volume today stands at 57.47K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for AKUMS in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AKUMS is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Akums Drugs and Pharmaceutical before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AKUMS. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AKUMS option chain page linked from this overview.
// similar in healthcare330 total